SunOpta’s first quarter results were met with a significant positive market reaction as the company exceeded Wall Street’s revenue and profit expectations. Management attributed this performance to broad-based volume growth across its plant-based beverage, fruit snack, and protein shake categories. CEO Brian Kocher noted that all major customer channels—including foodservice and club—delivered year-over-year growth, emphasizing that “the outperformance was probably more on the capacity creation side than it really was on the demand side.” The company’s ability to unlock manufacturing capacity allowed it to fulfill existing demand more efficiently, which was a key factor in its strong start to the year.
Is now the time to buy STKL? Find out in our full research report (it’s free).
SunOpta (STKL) Q1 CY2025 Highlights:
- Revenue: $201.6 million vs analyst estimates of $194.5 million (9.3% year-on-year growth, 3.7% beat)
- Adjusted EPS: $0.04 vs analyst estimates of $0.01 ($0.03 beat)
- Adjusted EBITDA: $22.39 million vs analyst estimates of $21.27 million (11.1% margin, 5.3% beat)
- The company slightly lifted its revenue guidance for the full year to $796.5 million at the midpoint from $790 million
- EBITDA guidance for the full year is $101 million at the midpoint, above analyst estimates of $100.1 million
- Operating Margin: 5.2%, in line with the same quarter last year
- Sales Volumes rose 12.2% year on year (23.5% in the same quarter last year)
- Market Capitalization: $720.5 million
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions SunOpta’s Q1 Earnings Call
-
Andrew Strelzik (BMO Capital Markets) asked about the drivers behind pipeline acceleration amid a choppy consumer environment. CEO Brian Kocher attributed growth to the non-discretionary nature of plant-based products and the company’s strong demand generation capabilities.
-
Jim Salera (Stephens, Inc.) questioned the timeline for resolving the wastewater bottleneck at the Midlothian facility. Kocher explained that the solution is underway with equipment ordered, and that production constraints are already factored into current guidance.
-
Jon Andersen (William Blair) requested details on the composition of the new business pipeline and its impact on capacity. Kocher clarified the pipeline is roughly 25% of annual revenue, diversified across product lines, with the majority of opportunities in plant-based beverages and broth.
-
John Baumgartner (Mizuho Securities) inquired about the sustainability of lower SG&A expenses. CFO Greg Gaba responded that the year-over-year decrease was largely timing-related due to stock compensation and not expected to repeat in future quarters.
-
Daniel Biolsi (Hedgeye) asked about the rationale and timing behind the newly announced share repurchase authorization. Gaba stated it would be opportunistic and contingent on achieving leverage targets and having excess cash.
Catalysts in Upcoming Quarters
Going forward, the StockStory team will watch (1) the pace at which SunOpta executes operational improvements and addresses the Midlothian facility constraint, (2) the conversion rate of its expanded new business pipeline into realized sales, and (3) whether gross margin expands as planned through efficiency gains and cost pass-throughs. The effectiveness of the share repurchase program and SunOpta’s ability to manage shifting input costs will also serve as key markers of execution.
SunOpta currently trades at $6.19, up from $4.54 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).
Our Favorite Stocks Right Now
Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.
While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.